SENESCO CHOOSES VGXI TO PRODUCE FACTOR 5A PLASMID.

Senesco Technologies, Inc., (AMEX:SNT), Brunswwick, N.J., has contracted with VGXI, Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the company's combination therapy consisting of the Factor 5A gene and siRNA against Factor 5A.

Senesco has previously reported positive

preclinical in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunodeficient mice. The Factor 5A plasmid being produced by VGXI, as Senesco's preclinical data has shown, should cause cancer cells to enter apoptosis, or programmed cell death.

"VGXI's manufacturing and technical expertise in producing plasmids for Senesco's planned toxicology study and ultimately our clinical trial led us to choose them. We are pleased to be working with a company that has such an outstanding reputation in the field," commented Bruce Galton, Senesco's president and CEO.

Henry Hebel, vice president of Operations for VGXI said, "We believe that our ability to quickly supply the preclinical and clinical needs of our clients will allow Senesco to rapidly advance their programs. We are continuing to expand our collaborative development services to meet the growing needs for a wide variety of plasmid based products."

About VGXI Inc.

VGXI Inc. is a leading manufacturer of DNA plasmids, and its cGMP and non-cGMP products have passed rigorous reviews by several international regulatory agencies. VGXI offers a wide variety of contract manufacturing services to outside client organizations. The company's cGMP manufacturing facility in The Woodlands, Texas is a flexible, purpose-built facility used for research, development, and clinical supply. The site includes 500-liter and 100-liter fermentors and incorporates a cost-effective process. VGX International also has initiated a project to build and operate a 3000-liter scale cGMP, DNA plasmid manufacturing facility in Asia.

About Senesco Technologies, Inc.

Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. Senesco takes its name from the scientific term for the aging of plant cells: senescence. Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress. The company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products.

For more information, vist http://www.senesco.com or call 281/296-7300.

Related Articles

  • The science of cellular suicide.
  • The science of cellular suicide From the earliest days of an organism's development, right up until the bitter end, new cells are born and old ones die. Moreover, cell death can occur in predictable patterns, especially during embryonic development. The ......
  • Thanks, Ma, my brain needed that.
  • Here's a compelling reason to remember Mother's Day next year: Infant mice deprived for just a single day of their mother's attention sustain greater than normal amounts of brain cell death during their postnatal development. Scientists conducting maternal deprivation studies ......
  • Gene determines when cells live or die.
  • When an amphibian makes the leap from tadpole to toad, the cells in its tail kill themselves because they're no longer needed. Biologists call this phenomenon programmed cell death, or apoptosis. It's a normal part of animal development, but no ......
  • And how do your plants' cells wither?
  • The cells of plants, like those of animals, must undergo apoptosis, or genetically programmed cell death, as a part of normal growth, report Hong Wang and his colleagues at the University of California, Davis. Scientists had suspected that apoptosis occurs ......
  • Therapy pits useful gene against tumor.
  • In about half of lung cancer cases, a gene called p53 has mutated and thus fails to encode a protein that oversees programmed cell death. In the absence of this protein, which helps curb the growth of damaged or abnormal ......
  • Biomedicine.
  • From Philadelphia, at the annual meeting of the American Association for Cancer Research Drug combination slows colon cancer Aspirin and other nonsteroidal anti-inflammatory drugs can retard the development of colorectal cancer. The medications appear to promote programmed cell death, a ......
  • Infection fighter can cause plaque buildups.
  • A molecule that usually protects the body's infection-fighting cells might also contribute to fatty buildups that coat arteries and lead to heart disease, according to researchers from the University of Texas Southwestern Medical Center at Dallas. The molecule, called apoptosis ......
  • Apoptosis lower in frontal balding areas. (Study of 16 Adult Men).
  • CHICAGO -- Although too much cell death may seem intuitively to be a cause of alopecia, there may be less apoptosis in the frontal balding areas than in the occipital region, Dr. Paul T. Rose said at the annual meeting ......
  • L-CYSTEINE: EFFECT ON CASPASE-3 ACTIVITY.
  • L-CYSTEINE: EFFECT ON CASPASE-3 ACTIVITY. David Ruff, Robert Jackson, Ephraim Gwebu, Department of Research, Oakwood College, 7000 Adventist Blvd, NW, Huntsville, Alabama 35896. Caspase-3 is an enzyme that is an important element in apoptosis or programmed cell death, a normal ......
  • Adverse effects of iron plus vitamin C. (Senior Division).
  • The effects that iron and ascorbate have on human cells were investigated to see if high concentrations of iron and iron plus ascorbate increase cell death. Jurkat cells grown in RPMI media were used. Iron concentrations of 10 and 20 ......
  • Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
  • Green tea or its constituents have long been touted as a health promoting substance including claims it may have cancer prevention properties. We previously reported the in vitro ability of one tea polyphenol, epigallocatechin gallate (EGCG), to induce apoptotic cell ......
  • Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism.
  • Paraskevas GP, Kapaki E, Petropoulou O, et al. J Neurol Sci 2003:215:51-55. Oxidative stress is an important mechanism of cell death in Parkinson's disease (PD) and brain ischemia. Vitamins C, E and A are important antioxidants and deficiency of these ......
  • Common protein may repair heart damage.
  • A protein that the heart produces during its development could be redeployed after a heart attack to help the organ repair itself, researchers at UT Southwestern Medical Center at Dallas have found. The new mouse-study findings show that the protein, ......
  • Common protein may repair heart damage.
  • A protein that the heart produces during the heart's development could be redeployed after a heart attack to help the organ repair itself, researchers at UT Southwestern Medical Center at Dallas have found. The new mouse-study findings show that the ......
  • New Drug May Block Cell Death After Ischemia.
  • NEW ORLEANS -- A new type of drug that prevents cell death after ischemia showed promise for preventing death and myocardial infarction in coronary bypass patients. Although this finding came in a major clinical trial with more than 11,000 patients, ......

Related Topics